Literature DB >> 16818784

Lymph node resident rather than skin-derived dendritic cells initiate specific T cell responses after Leishmania major infection.

Giandomenica Iezzi1, Anja Fröhlich, Bettina Ernst, Franziska Ampenberger, Sem Saeland, Nicolas Glaichenhaus, Manfred Kopf.   

Abstract

Langerhans cells have been thought to play a major role as APCs for induction of specific immune responses to Leishmania major. Although their requirement for control of infection has been challenged recently, it remains unclear whether they can transport Ag to lymph nodes and promote initiation of T cell responses. Moreover, the role of dermal dendritic cells (DCs), another population of skin DCs, has so far not been addressed. We have investigated the origin and characterized the cell population responsible for initial activation of L. major-specific T cells in susceptible and resistant mice. We found that Ag presentation in draining lymph nodes peaks as early as 24 h after infection and is mainly mediated by a population of CD11c(high)CD11b(high)Gr-1-CD8-langerin- DCs residing in lymph nodes and acquiring soluble Ags possibly drained through the conduit network. In contrast, skin-derived DCs, including Langerhans cells and dermal DCs, migrated poorly to lymph nodes and played a minor role in early T cell activation. Furthermore, prevention of migration through early removal of the infection site did not affect Ag presentation by CD11c(high) CD11b(high) DCs and activation of Leishmania major-specific naive CD4+ T cells in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16818784     DOI: 10.4049/jimmunol.177.2.1250

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  38 in total

Review 1.  The stromal and haematopoietic antigen-presenting cells that reside in secondary lymphoid organs.

Authors:  Shannon J Turley; Anne L Fletcher; Kutlu G Elpek
Journal:  Nat Rev Immunol       Date:  2010-11-19       Impact factor: 53.106

Review 2.  Duality at the gate: Skin dendritic cells as mediators of vaccine immunity and tolerance.

Authors:  Christopher J Nirschl; Niroshana Anandasabapathy
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

Review 3.  Regulation of immunity at tissue sites of inflammation.

Authors:  Dorothy K Sojka; Christopher A Lazarski; Yu-Hui Huang; Irina Bromberg; Angela Hughson; Deborah J Fowell
Journal:  Immunol Res       Date:  2009-01-31       Impact factor: 2.829

4.  Distinctive localization of antigen-presenting cells in human lymph nodes.

Authors:  Catherine E Angel; Chun-Jen J Chen; Oliver C Horlacher; Sintia Winkler; Thomas John; Judy Browning; Duncan MacGregor; Jonathan Cebon; P Rod Dunbar
Journal:  Blood       Date:  2008-11-05       Impact factor: 22.113

Review 5.  Immunogenicity of subcutaneously administered therapeutic proteins--a mechanistic perspective.

Authors:  Anas M Fathallah; Richard B Bankert; Sathy V Balu-Iyer
Journal:  AAPS J       Date:  2013-07-16       Impact factor: 4.009

Review 6.  The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells.

Authors:  William R Heath; Francis R Carbone
Journal:  Nat Immunol       Date:  2013-09-18       Impact factor: 25.606

Review 7.  Dendritic cell subsets in primary and secondary T cell responses at body surfaces.

Authors:  William R Heath; Francis R Carbone
Journal:  Nat Immunol       Date:  2009-11-16       Impact factor: 25.606

8.  Accelerated healing of cutaneous leishmaniasis in non-healing BALB/c mice using water soluble amphotericin B-polymethacrylic acid.

Authors:  Karina Corware; Debra Harris; Ian Teo; Matthew Rogers; Kikkeri Naresh; Ingrid Müller; Sunil Shaunak
Journal:  Biomaterials       Date:  2011-07-31       Impact factor: 12.479

9.  Deficiency of lymph node-resident dendritic cells (DCs) and dysregulation of DC chemoattractants in a malnourished mouse model of Leishmania donovani infection.

Authors:  Marwa K Ibrahim; Jeffrey L Barnes; E Yaneth Osorio; Gregory M Anstead; Fabio Jimenez; John J Osterholzer; Bruno L Travi; Seema S Ahuja; A Clinton White; Peter C Melby
Journal:  Infect Immun       Date:  2014-05-12       Impact factor: 3.441

10.  Immunization with a lentivector that targets tumor antigen expression to dendritic cells induces potent CD8+ and CD4+ T-cell responses.

Authors:  Luciene Lopes; Marie Dewannieux; Uzi Gileadi; Ranbir Bailey; Yasuhiro Ikeda; Christopher Whittaker; Matthew P Collin; Vincenzo Cerundolo; Mizuki Tomihari; Kiyoshi Ariizumi; Mary K Collins
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.